Patents by Inventor Kevin Charles LINDQUIST

Kevin Charles LINDQUIST has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NECTIN-4 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
    Publication number: 20250000991
    Abstract: The present disclosure provides nectin-4 antibody drug conjugates and pharmaceutical compositions thereof, and methods of using for the treatment of cancer.
    Type: Application
    Filed: June 19, 2024
    Publication date: January 2, 2025
    Inventors: Jeffrey Streetman BOYLES, Kyla Elizabeth DRISCOLL, Omar DURAMAD, Qianxu GUO, Rikke Baek HOLMGAARD, Kevin Charles LINDQUIST, Joshua Inshik PARK, Divya SAGAR, Mohan SRINIVASAN, Petra VERDINO, Jieyu ZHOU
  • ANTIBODIES HAVING CONDITIONAL AFFINITY AND METHODS OF USE THEREOF
    Publication number: 20230192839
    Abstract: Provided herein are antibodies with conditional affinity for an antigen. The affinity of an antibody with conditional affinity for an antigen may be altered by a small molecule agent. Antibodies with conditional affinity may be used therapeutically alone or in combination with other therapeutics to treat cancer and other diseases.
    Type: Application
    Filed: March 29, 2018
    Publication date: June 22, 2023
    Applicant: PFIZER INC.
    Inventors: Bijan Andre BOLDAJIPOUR, Javier Fernando CHAPARRO RIGGERS, Xiaodi DENG, Kevin Charles LINDQUIST, Spencer PARK, Edward Derrick PASCUA, Thomas John VAN BLARCOM